Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones

Blood

Volumn 115, Issue 24, 2010, Pages 5026-5036

  Isnardi, Isabelle ^a   Ng, Yen Shing ^a,d   Menard, Laurence ^a,d   Meyers, Greta ^a,d   Saadoun, David ^a   Srdanovic, Iva ^a   Samuels, Jonathan ^a,e   Berman, Jessica ^a   Buckner, Jane H ^b   Cunningham Rundles, Charlotte ^c   Meffre, Eric ^a,d  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CD40 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; AUTOANTIBODY; CD69 ANTIGEN; ICOSLG PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN; TNFRSF13B PROTEIN, HUMAN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CALCIUM TRANSPORT; CASE REPORT; CELL FUNCTION; CELL NUCLEUS; CLONAL ANERGY; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION PROFILING; GERMLINE MICRONUCLEUS; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; APOPTOSIS; CELL DIVISION; CYTOLOGY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL DIVISION; CLONAL ANERGY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; YOUNG ADULT;

EID: 77954684486     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-243071     Document Type: Article

References (50)

1. Nemazee D. Does immunological tolerance explain the waste in the B-lymphocyte immune system? experiment and theory. Ann N Y Acad Sci. 1995;764:397-401. (Pubitemid 26136190)
2. Radic MZ, Weigert M. Origins of anti-DNA antibodies and their implications for B-cell tolerance. Ann N Y Acad Sci. 1995;764:384-396. (Pubitemid 26136189)
3. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature. 2005;435(7042):590-597.
4. Goodnow CC, Crosbie J, Adelstein S, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988;334(6184):676-682.
5. Erikson J, Radic MZ, Camper SA, Hardy RR, Carmack C, Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature. 1991;349(6307):331-334. (Pubitemid 21912076)
6. Tsao BP, Chow A, Cheroutre H, Song YW, McGrath ME, Kronenberg M. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies. Eur J Immunol. 1993;23(9):2332-2339.
7. Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol. 2007;7(8):633-643.
8. Fulcher DA, Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med. 1994;179(1):125-134. (Pubitemid 24012977)
9. Cyster JG, Hartley SB, Goodnow CC. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire [see comments]. Nature. 1994;371(6496):389-395.
10. Nemazee DA, Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 1989;337(6207):562-566.
11. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature. 1991;353(6346):765-769.
12. Halverson R, Torres RM, Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol. 2004;5(6):645-650. (Pubitemid 38811890)
13. Healy JI, Dolmetsch RE, Timmerman LA, et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 1997;6(4):419-428.
14. Gauld SB, Benschop RJ, Merrell KT, Cambier JC. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol. 2005;6(11):1160-1167.
15. Merrell KT, Benschop RJ, Gauld SB, et al. Identification of anergic B cells within a wild-type repertoire. Immunity. 2006;25(6):953-962.
16. Duty JA, Szodoray P, Zheng NY, et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med. 2009;206(1):139-151.
17. Wehr C, Eibel H, Masilamani M, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004;113(2):161-171.
18. Wei C, Anolik J, Cappione A, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007;178(10):6624-6633.
19. Culton DA, Nicholas MW, Bunch DO, et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol. 2007;27(1):53-68.
20. Nicholas MW, Dooley MA, Hogan SL, et al. A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol. 2008;126(2):189-201.
21. Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99(5):1544-1551.
22. Warnatz K, Wehr C, Drager R, et al. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology. 2002;206(5):502-513.
23. Rakhmanov M, Keller B, Gutenberger S, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A. 2009;106(32):13451-13456.
24. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374-1377. (Pubitemid 37075812)
25. National Center for Biotechnology Information. Gene Expression Omnibus (GEO). http://www.ncbi.nlm.nih.gov/geo. Accessed G5E13917.
26. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34-48.
27. Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23(5):385-400.
28. Wehr C, Kivioja T, Schmitt C, et al. The EURO-class trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77-85.
29. Moir S, Ho J, Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205(8):1797-1805.
30. Ehrhardt GR, Hsu JT, Gartland L, et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med. 2005;202(6):783-791.
31. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med. 2008;205(8):1807-1817.
32. Radic MZ, Mackle J, Erikson J, Mol C, Anderson WF, Weigert M. Residues that mediate DNAbinding of autoimmune antibodies. J Immunol. 1993;150(11):4966-4977. (Pubitemid 23150364)
33. Isnardi I, Ng YS, Srdanovic I, et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity. 2008;29(5):746-757.
34. Goodnow CC, Brink R, Adams E. Breakdown of self-tolerance in anergic B lymphocytes. Nature. 1991;352(6335):532-536.
35. Hartley SB, Cooke MP, Fulcher DA,W. HA, Cory S, Basten A, Goodnow CC. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell. 1993;72(3):325-335.
36. Cooke MP, Heath AW, Shokat KM, et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med. 1994;179(2):425-438.
37. Nguyen KA, Mandik L, Bui A, et al. Characterization of anti-single-stranded DNA B cells in a non-autoimmune background. J Immunol. 1997; 159(6):2633-2644.
38. Mandik-Nayak L, Bui A, Noorchashm H, Eaton A, Erikson J. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med. 1997;186(8):1257-1267.
39. Cappione A III, Anolik JH, Pugh-Bernard A, et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest. 2005;115(11):3205-3216. (Pubitemid 41567585)
40. Pugh-Bernard AE, Silverman GJ, Cappione AJ, et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest. 2001;108(7):1061-1070.
41. Charles ED, Green RM, Marukian S, et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood. 2008;111(3):1344-1356.
42. Lyubchenko T, Dal Porto JM, Holers VM, Cambier JC. Cutting edge: complement (C3d)-linked antigens break B cell anergy. J Immunol. 2007;179(5):2695-2699.
43. Glynne R, Ghandour G, Rayner J, Mack DH, Goodnow CC. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol Rev. 2000;176:216-246.
44. Fujimoto M, Bradney AP, Poe JC, Steeber DA, Tedder TF. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity. 1999;11(2):191-200.
45. Pan C, Baumgarth N, Parnes JR. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity. 1999;11(4):495-506. (Pubitemid 29504204)
46. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34-47.
47. Allen CD, Ansel KM, Low C, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004;5(9):943-952.
48. Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8(5):362-371. (Pubitemid 351595218)
49. Cyster JG, Goodnow CC. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity. 1995;3(6):691-701.
50. Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 2004;20(4):441-453.